The University of Vermont 
DEPARTMENT OF PHARMACOLOGY, COLLEGE OF MEDICINE 
GIVEN BUILDING, BURLINGTON, VERMONT 05405 
(802) 656-2500 
November 10, 1982 
Dr. William J. Gartland, Jr. 
Director, Office of Recombinant DNA Activities, NIH 
Bethesda, Maryland 20205 
Dear Dr. Gartland: 
This will acknowledge your request for comments on the revised guidelines 
for research involving recombinant DNA. We do not have any problems with 
the guidelines at this University. There are 5 groups using recombinant 
DNA in their research and all of the work is at a P-1 level. The protocals 
are reviewed twice a year and are kept on file with the University IBC. 
The Institutional Biohazards Committee at the University of Vermont is 
charged with the review of the use of all biohazardous substances except 
the use of radio-isotopes. The IBC reviews protocals involving recombinant 
DNA, infectious agents and chemicals. This committee, however, does not 
become involved with the Medical Center Hospital of Vermont, the primary 
teaching hospital of the College of Medicine. 
Very truly yours. 
Jo Acting Chairman 
Chairman, Institutional Biohazards Committee 
JHG:mjd 
[ 541 ] 
